Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Details for Australian Patent Application No. 2004230946 (hide)

Owner Vertex Pharmaceuticals, Incorporated

Inventors Wilson, Keith P.; Perni, Robert P.; Bhisetti, Govinda Rao; Farmer, Luc J.

Agent Cullen & Co

Pub. Number AU-A-2004230946

PCT Pub. Number WO2004/092162

Priority 60/513,765 23.10.03 US; 10/412,600 11.04.03 US

Filing date 9 April 2004

Wipo publication date 28 October 2004

International Classifications

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 031/4155 - not condensed and containing further heterocyclic rings

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 031/425 - Thiazoles

A61K 031/401 - Proline

A61K 031/4965 - Non-condensed pyrazines

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/092162 Priority application(s): WO2004/092162

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230948-2-propylidene-19-nor-vitamin D compounds

2004230938-Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2